Evidence-based Management of Arrhythmogenic Right Ventricular Cardiomyopathy in Pregnancy

References

• Basso C , CorradoD, MarcusFI, NavaA, ThieneG. Arrhythmogenic right ventricular cardiomyopathy. Lancet, 373(9671), 1289–1300 (2009).
   PubMed Web of Science ®Google Scholar
• Jarcho JA , CorradoD, LinkMS, CalkinsH. Arrhythmogenic right ventricular cardiomyopathy. N. Engl. J. Med., 376(1), 61–72 (2017).
   PubMed Web of Science ®Google Scholar
• Ackerman M , AtkinsDL, TriedmanJK. Sudden cardiac death in the young. Circulation, 133(10), 1006–1026 (2016).
   PubMed Web of Science ®Google Scholar
• Luo FY , ChadhaR, OsborneC, KealeyA. Arrhythmogenic right ventricular cardiomyopathy (ARVC) in pregnancy: a case series of nine patients and review of literature. J. Matern. Fetal. Neonatal Med. doi: https://doi.org/10.1080/14767058.2020.1745176 ( Epub ahead of print).
   Web of Science ®Google Scholar
• Akdis D , BrunckhorstC, DuruF, SagunerAM. Arrhythmogenic Cardiomyopathy: Electrical and Structural Phenotypes. Arrhythmia Electrophysiol. Rev., 5(2), 90 (2016).
   PubMedGoogle Scholar
• Corrado D , Van TintelenPJ, McKennaWJet al. Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis. Eur. Heart J., 41(14), 1414–1427b (2020).
   PubMed Web of Science ®Google Scholar
• McKoy G , ProtonotariosN, CrosbyAet al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet, 355(9221), 2119–2124 (2000).
   PubMed Web of Science ®Google Scholar
• Norgett EE . Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum. Mol. Genet., 9(18), 2761–2766 (2000).
   PubMed Web of Science ®Google Scholar
• Que D , YangP, SongX, LiuL. Traditional vs. genetic pathogenesis of arrhythmogenic right ventricular cardiomyopathy. Europace, 17(12), 1770–1776 (2015).
   PubMed Web of Science ®Google Scholar
• Kirchhof P , FabritzL, ZwienerMet al. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation, 114(17), 1799–1806 (2006).
   PubMed Web of Science ®Google Scholar
• James CA , BhonsaleA, TichnellCet al. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J. Am. Coll. Cardiol., 62(14), 1290–1297 (2013).
   PubMed Web of Science ®Google Scholar
• Saberniak J , HasselbergNE, BorgquistRet al. Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members. Eur. J. Heart Fail., 16(12), 1337–1344 (2014).
   PubMed Web of Science ®Google Scholar
• Ducas RA , ElliottJE, MelnykSFet al. Cardiovascular magnetic resonance in pregnancy: insights from the cardiac hemodynamic imaging and remodeling in pregnancy (CHIRP) study. J. Cardiovasc. Magn. Reson., 16(1), 1 (2014).
   PubMedGoogle Scholar
• Iorga A , CunninghamCM, MoazeniS, RuffenachG, UmarS, EghbaliM. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol. Sex Differ., 8(1), 33 (2017).
   PubMedGoogle Scholar
• Metra M , CotterG, DavisonBAet al. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the relaxin in acute heart failure (RELAX-AHF) development program. J. Am. Coll. Cardiol., 61(2), 196–206 (2013).
   PubMed Web of Science ®Google Scholar
• Leo CH , JelinicM, NgHHet al. Vascular actions of relaxin: nitric oxide and beyond. Br. J. Pharmacol., 174(10), 1002–1014 (2017).
   PubMed Web of Science ®Google Scholar
• Dalal D , NasirK, BommaCet al. Arrhythmogenic right ventricular dysplasia. Circulation, 112(25), 3823–3832 (2005).
   PubMed Web of Science ®Google Scholar
• Hulot JS , JouvenX, EmpanaJP, FrankR, FontaineG. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation, 110(14), 1879–1884 (2004).
   PubMed Web of Science ®Google Scholar
• Hodes AR , TichnellC, TeRiele ASJMet al. Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy. Heart, 102(4), 303–312 (2016).
   PubMed Web of Science ®Google Scholar
• Gandjbakhch E , VarletE, DuthoitGet al. Pregnancy and newborn outcomes in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Int. J. Cardiol., 258, 172–178 (2018).
   PubMed Web of Science ®Google Scholar
• Wu L , LiangE, FanSet al. Effect of pregnancy in arrhythmogenic right ventricular cardiomyopathy. Am. J. Cardiol., 125(4), 613–617 (2020).
   PubMed Web of Science ®Google Scholar
• Marcus FI , McKennaWJ, SherrillDet al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation, 121(13), 1533–1541 (2010).
   PubMed Web of Science ®Google Scholar
• Krul SPJ , vander Smagt JJ, vanden Berg MP, SollieKM, PieperPG, van Spaendonck-ZwartsKY. Systematic review of pregnancy in women with inherited cardiomyopathies. Eur. J. Heart Fail., 13(6), 584–594 (2011).
   PubMed Web of Science ®Google Scholar
• Bauce B , DalientoL, FrigoG, RussoG, NavaA. Pregnancy in women with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Eur. J. Obstet. Gynecol. Reprod. Biol., 127(2), 186–189 (2006).
   PubMed Web of Science ®Google Scholar
• Castrini AI , LieØH, LerenISet al. Number of pregnancies and subsequent phenotype in a cross-sectional cohort of women with arrhythmogenic cardiomyopathy. Eur. Heart J. Cardiovasc. Imaging, 20(2), 192–198 (2019).
   PubMed Web of Science ®Google Scholar
• Billebeau G , EtienneM, Cheikh-KhelifaRet al. Pregnancy in women with a cardiomyopathy: outcomes and predictors from a retrospective cohort. Arch. Cardiovasc. Dis., 111(3), 199–209 (2018).
   PubMed Web of Science ®Google Scholar
• Corrado D , WichterT, LinkMSet al. Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement. Circulation, 132(5), 441–453 (2015).
   PubMed Web of Science ®Google Scholar
• Calkins H , CorradoD, MarcusF. Risk stratification in arrhythmogenic right ventricular cardiomyopathy. Circulation, 136(21), 2068–2082 (2017).
   PubMed Web of Science ®Google Scholar
• Agir AA , BozyelS, CelikyurtUet al. Arrhythmogenic right ventricular cardiomyopathy in pregnancy: a case report and review of the literature. Int. Heart J., 55(4), 372–376 (2014).
   PubMed Web of Science ®Google Scholar
• Lee LC , BathgateSL, MacriCJ. Arrhythmogenic right ventricular dysplasia in pregnancy: a case report. J. Reprod. Med. Obstet. Gynecol., 51(9), 725–728 (2006).
   Google Scholar
• Towbin JA , McKennaWJ, AbramsDJet al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Hear. Rhythm, 16(11), e301–e372 (2019).
   PubMed Web of Science ®Google Scholar
• Stadiotti I , PompilioG, MaioneAS, PilatoCA, D’AlessandraY, SommarivaE. Arrhythmogenic cardiomyopathy: what blood can reveal?Hear. Rhythm, 16(3), 470–477 (2019).
   PubMed Web of Science ®Google Scholar
• Grewal J , SilversidesCK, ColmanJM. Pregnancy in Women with Heart Disease. Heart Fail. Clin., 10(1), 117–129 (2014).
   PubMed Web of Science ®Google Scholar
• Tanous D , SiuSC, MasonJet al. B-type natriuretic peptide in pregnant women with heart disease. J. Am. Coll. Cardiol., 56(15), 1247–1253 (2010).
   PubMed Web of Science ®Google Scholar
• Yancy CW , JessupM, BozkurtBet al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J. Am. Coll. Cardiol., 70(6), 776–803 (2017).
   PubMed Web of Science ®Google Scholar
• Schaefer C . Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity. Birth Defects Res. Part A - Clin. Mol. Teratol., 67(8), 591–594 (2003).
   PubMedGoogle Scholar
• Cooper WO , Hernandez-DiazS, ArbogastPGet al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N. Engl. J. Med., 354(23), 2443–2451 (2006).
   PubMed Web of Science ®Google Scholar
• Lydakis C , LipGYH, BeeversM, BeeversDG. Atenolol and fetal growth in pregnancies complicated by hypertension. Am. J. Hypertens., 12(6), 541–547 (1999).
   PubMed Web of Science ®Google Scholar
• Sliwa K , FettJ, ElkayamU. Peripartum cardiomyopathy. Lancet, 368(9536), 687–693 (2006).
   PubMed Web of Science ®Google Scholar
• McNamara DM , ElkayamU, AlharethiRet al. Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC study (Investigations of Pregnancy-Associated Cardiomyopathy). J. Am. Coll. Cardiol., 66(8), 905–914 (2015).
   PubMed Web of Science ®Google Scholar
• Riester A , ReinckeM. Progress in primary aldosteronism: Mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy. Eur. J. Endocrinol., 172(1), R23–R30 (2015).
   PubMed Web of Science ®Google Scholar
• Elkayam U . Risk of Subsequent Pregnancy in Women With a History of Peripartum Cardiomyopathy. J. Am. Coll. Cardiol., 64(15), 1629–1636 (2014).
   PubMed Web of Science ®Google Scholar
• Iriyama T , KameiY, KozumaS, TaketaniY. Management of patient with arrhythmogenic right ventricular cardiomyopathy during pregnancy. J. Obstet. Gynaecol. Res., 39(1), 390–394 (2013).
   PubMed Web of Science ®Google Scholar
• Güdücü N , KutaySS, ÖzençE, ÇiftçiÇ, YiğiterAB, İşçiH. Management of a rare case of arrhythmogenic right ventricular dysplasia in pregnancy: a case report. J. Med. Case Rep., 5(1), 300 (2011).
   PubMedGoogle Scholar
• Meidahl Petersen K , Jimenez-SolemE, AndersenJTet al. β-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study. BMJ Open, 2(4), e001185 (2012).
   PubMed Web of Science ®Google Scholar
• Bateman BT , PatornoE, DesaiRJet al. Late Pregnancy Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia. Pediatrics, 138(3), e20160731–e20160731 (2016).
   PubMed Web of Science ®Google Scholar
• Enriquez AD , EconomyKE, TedrowUB. Contemporary management of arrhythmias during pregnancy. Circ. Arrhythmia Electrophysiol., 7(5), 961–967 (2014).
   PubMed Web of Science ®Google Scholar
• Basso C , CorradoD, BauceB, ThieneG. Arrhythmogenic right ventricular cardiomyopathy. Circ. Arrhythmia Electrophysiol., 5(6), 1233–1246 (2012).
   PubMed Web of Science ®Google Scholar
• Regitz-Zagrosek V , Roos-HesselinkJW, BauersachsJet al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur. Heart J., 39(34), 3165–3241 (2018).
   PubMed Web of Science ®Google Scholar
• Limongelli G , RubinoM, EspositoA, RussoM, PacileoG. The challenge of cardiomyopathies and heart failure in pregnancy. Curr. Opin. Obstet. Gynecol., 30(6), 378–384 (2018).
   PubMed Web of Science ®Google Scholar
• Goland S , ElkayamU. Peripartum cardiomyopathy. Curr. Opin. Cardiol., 33(3), 347–353 (2018).
   PubMed Web of Science ®Google Scholar
• Podymow T , AugustP. Update on the Use of Antihypertensive Drugs in Pregnancy. Hypertension, 51(4), 960–969 (2008).
   PubMed Web of Science ®Google Scholar